NeuroBo Pharmaceuticals Inc - Company Profile
Powered by 
All the data and insights you need on NeuroBo Pharmaceuticals Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date NeuroBo Pharmaceuticals Inc Strategy Report
- Understand NeuroBo Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
NeuroBo Pharmaceuticals Insights
Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.
A sample of NeuroBo Pharmaceuticals Insights data
| Headline | Published | Journalists |
|---|---|---|
| Deserunt mollit sunt Lorem laborum do id aliqua dolore | 15 Sep 2020 | Lorem |
| Gemphire’s Phase IIa gemcabene for NAFLD and NASH draws some expert optimism on mechanism but caveats remain; earlier data inference may be unfitting | 05 Mar 2018 | Reynald Castaneda |
| Viking’s possible Phase III VK2809 trial design ultimately depends if company favours hypercholesteremia or NAFLD; data in both a market advantage – experts | 05 Jan 2018 | Reynald Castaneda |
| Gemphire’s future Phase III severe hypertriglyceridemia trial of gemcabene has experts divided over need for CVOT outcomes | 09 Nov 2017 | Fiona Barry, Hannah Wilgar |
Feature
Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.
Benefit
Drug Insights:
- Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
- Material intelligence on competitors, including breaking news
- Insight on companies’ business development needs and strategies
Outsourcing Insights:
Insight on companies’ CRO and business development needs, strategies and relationships
Value
Remove risk and uncertainty
Gain a competitive edge
Secure actionable leads
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer